

Trump SLASHES Drug Prices With Executive Order!
May 14, 2025
A sweeping executive order aims to slash prescription drug prices in the U.S., with the health department tasked to negotiate new price tags. The discussion humorously critiques political absurdities and examines the influence of pharmaceutical lobbying. There's also a look at Trump's unexpected negotiations related to Middle Eastern hostages and the potential implications for recognizing a Palestinian state. The podcast effectively navigates through the complexities of political maneuvering, drug pricing reforms, and ongoing humanitarian crises.
AI Snips
Chapters
Transcript
Episode notes
Trump Targets Big Pharma Pricing
- Trump's executive order sets a 30-day deadline for drugmakers to lower U.S. drug prices voluntarily.
- If not, the government will tie U.S. prices to lower international prices, challenging Big Pharma's profit model.
U.S. Subsidizes Global Pharma Costs
- The U.S. pays far more for drugs than Europe, subsidizing global pharmaceutical profits.
- Trump's plan shifts cost burden to other countries to make drug pricing fairer for Americans.
U.S. Overpays Even After Negotiations
- After price negotiations, the U.S. still pays significantly more for drugs than other countries.
- The government is highly corrupted, limiting true price negotiation with Big Pharma.